Navigation Links
Global Med Technologies(R) to Report Third Quarter and Nine-Month Financial Results on Thursday, November 13, 2008
Date:11/3/2008

nc. is an international medical software company which develops regulated and non-regulated software products and services for the healthcare industry. As a leading provider of blood and laboratory software applications and services, Global Med's products are deployed in 20 countries and serve over 1,600 transfusion centers, blood banks and laboratories.

Global Med's U.S. division, Wyndgate Technologies(R), provides Vein-to-Vein(R) tracking through its Donor Doc(TM), SafeTrace(R), SafeTrace Tx(R) and ElDorado Donor(TM) software products. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply.

Global Med's European subsidiary, Inlog, SA, is a leading provider of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally. Inlog's products include EdgeBlood*, EdgeTrack*, EdgeCell, EdgeLab and SAPANET.

Global Med's U.S. division, eDonor(R), provides a web-based donor relationship management system that integrates recruitment, scheduling, retention and fulfillment for national as well as local community blood centers and hospitals. eDonor's products and services are designed to complement Global Med's strong line of international blood management and laboratory information software and service solutions.

Global Med's U.S. subsidiary, PeopleMed(R), Inc., provides cost-effective customized software validation, consulting and compliance solutions to hospitals and donor centers.

For more information about Global Med's products and services, please call 800-996-3428 or visit http://www.globalmedtech.com, http://www.peoplemed.com, http://www.inlog.com,

SOURCE Global Med Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
2. Tata Consultancy Services to Support Roches Global Capacity Building Initiative
3. Creative Technology Services Enhances its Global Competitiveness with Additional Regulatory Certifications
4. Briefing on a new Web resource to address global drinking water crisis
5. MDS Pharma Services Wins Award for Management of Global Malaria Trial
6. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
7. Resonant Medical Appoints New Vice President of Global Sales
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. The era of global aging: GSAs annual meeting to present new research on hot topics in aging
10. MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers
11. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)...; Machine post You Tube video demonstrating the Re... Landover, MD (PRWEB) November 2...earning what a really rugged waterproof keyboard c...Keyboard vs Washable Competitors Keyboard HD&rdquo...he premium, Really Cool Keyboard from Man & M...
(Date:11/21/2009)...s for an unprecedented expansion of federally-fund...t for preserving and protecting human life? If the...aine Yoest ,, WASHINGTON, Nov. 21 /PRNewswire...resident and CEO Dr. Charmaine Yoest responded to ...owing statement: ,, "This was a pro-abortion v...
(Date:11/21/2009)... 2009 Test Test Test Tes...t Test Test Test Test Test,Test Test Test Test Tes...t,Test Test Test Test Test Test Test Test Test Tes...st More test More test More test More test,More te...st More test More,test More test , , Please ig...
(Date:11/21/2009)...Hall, president and chief executive officer of the...e following statement regarding the inclusion of c...nnual wellness for Medicare beneficiaries in "...ot; that was introduced last night: , ...9 -- Eric J. Hall, president and chief executive o...
(Date:11/20/2009)... /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals ...areholders will be held on Monday, December 21, 20...oval of two special resolutions. The first special...f all or substantially all of the assets of NUCRYS...asset purchase agreement dated November 10, 2009 a...
Breaking Medicine News(10 mins):Health News:Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube 2Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3
...sh study, Women's Health in the Lund Area, was exp...sis of the data collected now reveals a small but ...xposure [EHP 113:1627-1631]//. This suggests that ... smoking and from dietary sources, particularly sh...
...cates that bronchiolo–alveolar carcinoma frequentl... The acoustic–physical conditions of t...r the sonographic diagnosis of pulmonary diseases.... pattern of bacterial pneumonia is predominantly w...
...l be the first in United Kingdom to perform a Live... Health Minister Andy Kerr said that in 2006 five ...n the next year//. In live liver regeneration ...ion to full size of the liver occurs both in the d...
...eensland Institute of Medical Research (QIMR) have...d number of sunspots which are precursors to skin ...f the American Academy of Dermatology. Aspirin...rtant for the growth of blood vessels. Angiogenesi...
...Health care accreditation standards that will make...enic conditions. Healthcare accreditation has beco...s and physicians providing health care which may l...Uniform accreditation system for health care indus...
...osed circuit, where Umbilical cord blood (UCB) col...to reduce the contamination risk and to speed the ...pear in the journal Blood Cells, Molecules, and Di... marrow or peripheral blood for treatment of sever...
Other Medicine News:Health News:The Exposure Of Cadmium And Its Effects On Kidneys 2Health News:NABH Health accreditations final draft to be released by this month 2Health News:A Novel System For Clinical Banking Of Umbilical Cord Blood 2
(Date:11/20/2009)...0 Reportlinker.com announces that ...atalogue. ,, Medical Adhesives and Sealants - ...r.com/p0164242/Medical-Adhesives-and-Sealants---A-...m_medium=pr&utm_campaign=prnewswire ,, Th... preeminence in medical devices and equipments. Cu...
(Date:11/20/2009)...Pa., Nov. 20 In respons...ons why currently available medications designed t..., ECRI Institute, an independent nonprofit organiz...inasteride for Prevention of Prostate Cancer for ... York Times article, " Drugs to Deter Some Cancer...
(Date:11/19/2009)... 19 Warner Chilcott plc (Nasdaq: ...ly announced secondary offering of 20,000,000 of i....25 per share. The selling shareholders include f...rchant Banking, J.P. Morgan Partners (advised by C...tain other institutional investors and members of ...
Breaking Medicine Technology:Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Spherix Reports Second Quarter 2009 Earnings 13596 1Spherix Reports Second Quarter 2009 Earnings 13596 2Spherix Reports Second Quarter 2009 Earnings 13596 3Spherix Reports Second Quarter 2009 Earnings 13596 4Spherix Reports Second Quarter 2009 Earnings 13596 5Spherix Reports Second Quarter 2009 Earnings 13596 6Spherix Reports Second Quarter 2009 Earnings 13596 7Spherix Reports Second Quarter 2009 Earnings 13596 8US born Asian American women more likely to think about attempt suicide 54659 1US born Asian American women more likely to think about attempt suicide 54659 2US born Asian American women more likely to think about attempt suicide 54659 3Scientists link genetic glitches to common childhood cancer 9603 1Scientists link genetic glitches to common childhood cancer 9603 2
...ptive Informatics, the industry,s leading eClinica...nternational Corporation (Nasdaq: PRXL ), today ... investigators apply the new 1.1 version of RECIST... medical imaging-based oncology trials. Perceptive...ECIST Working Group, has incorporated into its REC...
...rial investigating the effectiveness of Intercell,...th an injectable H5N1 pandemic influenza vaccine s... funded by HHS - this is the second study conducte..., , - Intercell,s VE Patch may reduce the dosage ...fluenza outbreak with only a single dose vaccine a...
Other Medicine Technology:Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials 2Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials 3Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials 4Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials 5Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS 2Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS 3
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: